Malignancy in endometrial polyps: a 12-year experience

被引:58
作者
Baiocchi, Gabriela [1 ]
Manci, Natalina [2 ]
Pazzaglia, Michela [1 ]
Giannone, Laura [1 ]
Burnelli, Liliana [1 ]
Giannone, Ettore [1 ]
Fratini, Daniela [3 ]
Di Renzo, Gian Carlo [1 ]
机构
[1] Santa Maria Misericordia Univ Hosp, Dept Obstet & Gynecol, Perugia, Italy
[2] Univ Roma La Sapienza, Policlin Umberto I, Dept Gynecol & Obstet, Rome, Italy
[3] Univ Perugia, Inst Pathol, I-06100 Perugia, Italy
关键词
endometrial; endometrial cancer; hysteroscopy; polyps; risk factors; SALINE INFUSION SONOGRAPHY; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; TAMOXIFEN; CANCER; RISK; HYSTEROSCOPY;
D O I
10.1016/j.ajog.2009.05.055
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Endometrial polyps (EPs) are common pathological lesions in all women. The objective of this study was to evaluate the risk of malignancy of EPs and to investigate whether clinical parameters may predict the histopathologic features of these lesions. STUDY DESIGN: A retrospective study was conducted from January 1995 to December 2006 and all consecutive 1242 cases with clinical EPs were included. The charts of all these women were reviewed and clinical data were related to histopathologic results. RESULTS: Histologically, polyps were distinguished as benign, premalignant, and malignant. Overall, 95.2% benign polyps, 1.3% premalignant, and 3.5% malignant lesions were detected. When clinical variables were considered, patient age, menopause, presence of abnormal uterine bleeding, and hypertension were statistically significant characteristics related to premalignant and malignant features. CONCLUSION: Older menopausal bleeding patients with hypertension are at high risk for premalignant and malignant polyps. Therefore, besides abnormal bleeding symptoms, this kind of patient needs to have the polyps removed.
引用
收藏
页码:462.e1 / 462.e4
页数:4
相关论文
共 27 条
[1]  
Anastasiadis PG, 2000, EUR J GYNAECOL ONCOL, V21, P180
[2]   Endometrial polyps in pre- and postmenopausal women: Factors associated with malignancy [J].
Antunes, A., Jr. ;
Costa-Paiva, L. ;
Arthuso, M. ;
Costa, J. V. ;
Pinto-Neto, A. M. .
MATURITAS, 2007, 57 (04) :415-421
[3]   The risk of premalignant and malignant pathology in endometrial polyps [J].
Bakour, SH ;
Khan, KS ;
Gupta, JK .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2000, 79 (04) :317-320
[4]   The malignant potential of endometrial polyps [J].
Ben-Arie, A ;
Goldchmit, C ;
Laviv, Y ;
Levy, R ;
Caspi, B ;
Huszar, M ;
Dgani, I ;
Hagay, Z .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 115 (02) :206-210
[5]   Risk and prognosis of endometrial cancer after tamoxifen for breast cancer [J].
Bergman, L ;
Beelen, MLR ;
Gallee, MPW ;
Hollema, H ;
Benraadt, J ;
van Leeuwen, FE .
LANCET, 2000, 356 (9233) :881-887
[6]   The bright edge of the endometrial polyp [J].
Caspi, B ;
Appelman, Z ;
Goldchmit, R ;
Ashkenazi, M ;
Haruvy, Y ;
Hagay, Z .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2000, 15 (04) :327-330
[7]   Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients [J].
Cheng, WF ;
Lin, HH ;
Torng, PL ;
Huang, SC .
GYNECOLOGIC ONCOLOGY, 1997, 66 (02) :233-237
[8]   Sonohysterography in premenopausal women with and without abnormal bleeding [J].
Clevenger-Hoeft, M ;
Syrop, CH ;
Stovall, DW ;
Van Voorhis, BJ .
OBSTETRICS AND GYNECOLOGY, 1999, 94 (04) :516-520
[9]   Postmenopausal endometrial pathologies with tamoxifen treatment: Comparison between hysteroscopic and hysterectomy findings [J].
Cohen, I ;
Azaria, R ;
Aviram, R ;
Bernheim, J ;
Tepper, R ;
Cordoba, M ;
Beyth, Y .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 48 (03) :187-192
[10]   Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women [J].
de Almeida, ECS ;
Nogueira, AA ;
dos Reis, FJC ;
Ramalho, LNZ ;
Zucoloto, S .
MATURITAS, 2004, 49 (03) :229-233